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ABSTRACT This paper reports research using data in the 
Nijmegen Family Practice Monitoring Project, One part of the 
research is follow-up, after 17 y, of a 1977 trial of dietary advice 
for patients with hypertension or a family history of premature 
cardiovascular disease. In the intervention group, 840 patients 
were given health education every 2 mo by trained practice nurses 
for I y. There wore 497 patients with similar coronary risk factors 
in the control group, who received usual care. One year after the 
intervention a significant decrease was found (and published) in 
serum cholesterol concent rat ions and blood pressure in the inter­
vention group, By the time of the 1995 reexaminations, however, 
there were no differences in coronary risk factors between the two 
groups. Blood pressures had come down, more so in the control 
group, and the percentage of smokers had decreased equally in 
both groups. There were no significant differences in intake of 
dietary fat or in type of fat. The lack of difference was still found 
when the groups were divided into those with serum cholesterol 
concentrations >  and <  6.5 mmol/L. A second part of the research 
was to investigate in 1995 the relation between patients1 stage of 
change of fat intake and their dietary intake. It was found that those 
in stage 5 (sustaining desired changes in behavior) had the lowest 
saturated fat intake. Since 1977 both groups have been treated 
equally if hypertension was diagnosed. The two groups were not 
managed differently with regard to dietary advice after 1977,
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INTRODUCTION
Nutritional advice is one of the cornerstones of primary and 
secondary prevention of cardiovascular diseases. Promotion of 
healthy food in the general population aims at lowering the 
development of atherosclerosis* Subjects with an established 
elevated risk of cardiovascular disease, among others, are 
counseled to change their fat intake. The objective of this 
counseling is to slow down or postpone the development of 
atherosclerosis: ie, secondary prevention. Secondary preven­
tion of cardiovascular disease requires a person-to-person ap­
proach over a long time, and this form of prevention has been 
promoted in the personal care that is a part of family practice.
Nutritional advice in the secondary prevention of cardiovas­
cular disease can be directed at lowering intake of saturated fat 
and increasing intake of polyunsaturated fat to reduce blood 
cholesterol concentrations, at lowering energy intake to reduce
body mass, and at restricting salt intake to lower blood 
pressure.
To be effective, interventions should be maintained over a 
long period of time. For smoking cessation, long-term out­
comes of intervention in general practice have been disappoint­
ing (1, 2). Dietary advice concerning weight: reduction as well 
has yielded only limited long-term effects, But little is known 
of the long-term effect of nutritional advice to lower blood lipid 
concentrations. In short-term intervention studies a significant 
decrease in low-density-lipoprotein (LDL) cholesterol was 
found with both a diet with low total fat and a diet with reduced 
saturated fat compensated by increased unsaturated fat (3). 
Changes in serum lipid concentrations were similar to those 
seen with cholesterol-lowering drugs.
Strandberg et al (4) found no differences in risk factors 
between intervention and control groups 5 y after a trial, 
although at the end of the trial all risk factors were significantly 
lower in the intervention group. Treatment of hyperlipidemia 
as well as of hypertension has proved to be effective, but there 
is a marked difference in effectiveness between antihypertipi- 
demic and anti hypertensive therapy in primary care settings 
and the benefits reported in randomized trials (5, 6). In many 
patients in general practice, hyperlipidemia and hypertension 
are controlled inadequately (7). It can be assumed that an 
important factor in success is an individual’s perceived need to 
change his or her nutrition habits. This perception can be 
evaluated by determining a patient’s stage of change, which 
ranges from precontemplation to maintenance (8, 9).
The aim of the present study was to assess the long-term 
effect of nutritional advice after screening for cardiovascular 
risk, Blood cholesterol concentrations and stages of change 
were measured in two groups of patients, 17 y after their 
participation in a primary care-based screening: a group with 
an elevated risk at the initial screening and a group with 
low-normal risk at the initial screening.
DESIGN AND RESEARCH PROCEDURES
Plasma cholesterol, stage of change, smoking status, body 
weight, and blood pressure were measured in 1994-1995 in 
subjects who had taken part in a family practice-based sereen-
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ing for cardiovascular risk in 1977 (10). Participants were 
recruitcd from the family practices of the Nijmegen Monitoring 
Project, the research network of the Nijmegen University De­
partment of Family and Social Medicine. The objective of this 
research network is to study the long-term outcome of chronic 
diseases, including cardiovascular disease, in family practice. 
The clinical condition of patients under treatment is systemat­
ically monitored and feedback is given to the family physician 
responsible for their treatment.
The 1977-1978 screening
The screening in 1977-1978 took place in six practices in the 
Nijmegen region. In the period from 1 February .1977 until I 
February 1978 all patients between 20 and 50 y of age who 
visited their doctor were invited for screening. The whole 
population consisted of 10 284 patients. The screening was 
performed by specially trained practice nurses and consisted of 
a medical and family history on cardiovascular diseases; smok­
ing was assessed with use of a standard questionnaire. Body 
weight was measured without shoes on a balance scale; blood 
pressure was measured with a mercury sphygmomanometer. 
Systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) were measured twice on the right arm with the patient 
sitting after a rest period.
Serum cholesterol concentration was measured with the 
Liebermann-Burchard reagent, with Huang modification, at the 
laboratory of the Wageningen Agricultural University. The 
laboratory took part in the Cooperative Cholesterol Standardi­
sation Program of the World Health Organization with the 
Center for Research in Blood Lipids in Atlanta as a reference 
( 1 1 ).
A cardiovascular risk profile was drawn for every participant 
and those with elevated risk were referred to their family 
physician. The criteria for the risk profile were derived from 
the Coronary Risk Handbook, developed by the American 
Heart Association (12)* without the criteria for electrocardio­
gram abnormalities. Hypertension was defined as SBP >  160 
or DBP >  95 mm Mg or both in men aged <  40 y, SBP >  160 
or DBP >  100 mm Hg or both in men >  40 y, SBP >  180 or 
DBP >  100 mm Hg or both in women aged <  40 y, and SBP 
> 180 or DBP >  105 mm Hg or both in women aged ^  40 y. 
A family history of cardiovascular disease (cardiovascular dis­
ease before the age of 65 y in first-degree relatives) with 
borderline hypertension was also a reason for intervention. 
Borderline hypertension was defined In men as SBP between 
140 and 160 or DBF between 90 and 95 mm Hg or both in men 
aged <  40 y and SBP between 140 and 160 or DBP between 96 
and 100 mm Hg or both in men aged ¡¡& 40 y. For women, 
borderline hypertension was defined as SBP between 160 and 
180 or DBP between 95 and 100 mm Hg or both in women 
aged <  40 y and SBP between 160 and 180 or DBP between 
100 and 105 mm Hg or both in women aged ^  40 y.
The six practices were randomly divided into four interven­
tion and two control practices. The 20% of all participants with 
the highest risk scores were invited to participate in the inter­
vention in these four practices. In the intervention practices, 
family physicians received support for 1 y in the follow-up of 
the identified high-risk patients. Patients were given health 
education every 2 mo by trained practice nurses, whereas the 
control family physicians prescribed unsupported advice. Thus, 
the intervention compared the outcome of cardiovascular risk
in high-risk patients under supervised care with outcome in 
high-risk patients under usual care.
After this intervention study, all practices received (com­
puter-assisted) monitoring in 1982 of the follow-up of their 
patients with hypertension and later with diabetes. AH cardio­
vascular events were registered. This developed into the 
Nijmegen Monitoring Project network of the Department of 
Family and Social Medicine.
The 1994-1995 rescreening
In 1994-1995 the long-term outcome of the 1977-1978 
screening and intervention was studied. The first step was to 
establish whether participants of the screening were still alive 
and lived in the practice area. The files of patients who had 
died were studied for cause of death, and For patients who had 
moved to another area, their new family physician was con­
tacted to establish their current health status.
The subjects still living in the practice area were considered 
for the follow-up study. All with an elevated cardiovascular 
risk at: the 1977-1978 screening were invited, as were a random 
20% sample of those with a low-normal cardiovascular risk at 
that time. The following information was collected at the 
rescreening. /) Cardiovascular events since 1977 were re­
corded based on the computerized practice records. 2) Smoking 
status, body mass index, and blood pressure were measured as 
in 1977. 3) Nonfasting serum cholesterol concentrations were 
measured with the enzymatic method at the laboratory of the 
Canisius Wilhelmina Hospital at Nijmegen. The quality control 
standards of the national laboratory foundation were met. The 
internal quality control data of the laboratory were analyzed to 
detect laboratory drifts. 4) Fat intake and dietary attitude were 
measured in the local family practice by trained research as­
sistants. The questionnaire used assessed fat intake and the 
patient’s attitude toward fat intake and the barriers in changing 
toward consumption of healthy foods. Patients1 attitudes to­
ward Fat intake were established by use of a stage-of‘-change 
algorithm. The short questionnaire defines an individual's 
stage of dietary fat reduction and has been validated (13, 14). 
The stage-of-ehange model is a dynamical model that classifies 
behavior into five stages: precontemplation (not yet consider­
ing the behavioral change of interest), contemplation (consid­
ering change), preparation (actually planning change), action 
(actively changing), and maintenance (sustaining the desired 
changes in behavior),
Current fat intake and stage of dietary change were treated as 
independent variables and blood cholesterol in 1995 was the 
dependent variable. Correlations were assessed between fat 
intake and I) serum cholesterol concentrations and 2) stage of 
change in dietary attitudes. Correlations were also computed 
between the stage of dietary change and serum cholesterol 
concentrations. The SAS program (SAS Institute, Inc, Cary, 
NC) was used for analysis.
RIST ;rs
The study population in 1977 by age and sex is shown in 
Table 1. A total of 7092 patients participated in 1977 (68,9% 
of the total population invited for screening). At the basic
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TABLE I
SUuly population in 1977 by age and sex
Men 
(n »  3404)
Women 
(n =  3688)
Total 
( h «  7092)
20-29 y 987 1207 2194
30-39 y 1384 1401 2785
40-49 y 1033 1080 2113
TABLE 2
Mean value of coronary risk factors in high-risk subjects in the 
intervention and control groups in 1977 and 19951
Intervention group Control group
(a «  360) (/i ^  112)
Risk factor J977 1995 1977 1995






88.5 ± 10.) 
144.0 ± 16.5 
60.0 
25.4 ± 3.2




91.8 S 14.4 
149.7 i  17,7 
53.6 
25.5 ± 3.2
84.6 ± 8,4 
139.8 2  17.0 
34.2 
26.5 ï  3.6
1 .v ±  SE. Mean age of both groups was 56 y (range: 39-68 y). DBP, 
diastolic blood pressure; SBP, systolic blood pressure.
screening the high-risk group consisted of 840 subjects in the 
intervention group and 497 subjects in the control group. In 
1995 there were 938 subjects alive, 630 of the intervention 
group and 308 of the control group. Seventy-six subjects died 
and 323 had moved from the practice area.
As shown in Table 2, except for blood pressure, mean values 
for the coronary risk factors did not differ significantly between 
the intervention and control groups. Systolic and diastolic 
blood pressure decreased more in the control group than in the 
intervention group, but patients in the control group had higher 
blood pressures at the 1977 screening,
Dietary fat intake» measured with the questionnaire, is shown 
in Table 3. There was no difference in mean fat intake between 
the two groups. To see whether there was a relation between fat
TABLE 3
Mean fat intake (measured with the food-frequency questionnaire) and 
serum cholesterol concentration in 1995/
Intervention group 
(// «  360)
Control group 
(// « ! (2)
Fat (g)
Total 105.8 42,5 103.3 i 37.1
Saturated 38.0 4- 15.4 38.5 13.5
Mono unsaturated 35.9 it 16.4 36.1 — 15.1
Polyunsaturated 25.7 Ì 11.9 22.2 10.6
Fat (% of energy)
Total 38.5 ± 6.9 39.3 i 7.8
Saturated 13.8 2.7 14.7 3.2
Monounsaturaied 13.0 ± 3.2 13.7 fir* 3,6
Poly tin saturated 9,4 3.2 8.4 fé|^*** 3.1
Serum cholesterol (mmol/L) 6.5 -b 1.1 6.5 Mr* 1.3
1X ± SE.
intake and serum cholesterol, we compared fat intake with 
serum cholesterol for different groups. The cholesterol guide­
lines of the Dutch College of General Practitioners advise 
treatment at a serum total cholesterol concentration of 6.5 
mmol/L in combination with one or more cardiovascular risk 
factors. In light of that guideline we used a serum cholesterol 
concentration of 6.5 mmol/L as the cutoff Fat intake and serum 
cholesterol concentrations in 1977 for the intervention and 
control groups are shown in Table 4. There was no relation 
between high and low blood cholesterol in the intervention and 
control groups as measured in 1977 ancl fat intake in 1995, 
despite the intervention in the high-cholesterol intervention 
group in 1977.
To look for an influence of nutrition counseling on dietary 
behavior we investigated the relation between high blood cho­
lesterol in 1977 and the stage of change in 1995. There was no 
relation between intervention ancl control groups and the stage 
of change for either high or low blood cholesterol.
To determine the consequences of our findings for general 
practice, we counted the proportion of patients who currently 
need special attention for their food habits. Dietary guidelines
TABLE 4
Mean fat intake in 1995 in relation to blood cholesterol in 1977 for the intervention and control groups'









Fat (% of energy)
Total 38.7 £ 6.9 39.9 ± 7.4 38.3 ± 7,0 US OC pc
Saturated 14.1 ± 2.9 14.9 ±  3.3 13.5 ± 2.4 14.4 t  3.1
Monounsaturaied 13.2 ± 3.2 14.0 ± 3 .6 f 2.7 ± 3.1 13.0 t  3.5
Polyunsaturated 9.1 ± 2.9 8.4 ±  3.0 9.8 ± 3.4 8.4 ± 3,2
Fat (g)
Total 106 ± 45 104 i  35 105 ±  39 100 ± 43
Saturated 38.7 ± 16.6 38.8 ± 12.8 37.1 ± 13.6 37.8 ± 15.0
Monounsaturaied 36.5 ± 17.5 36.8 ±  14.5 35.1 £  14.8 34.5 :t 16.4
Polyunsaturated 24.7 ± 11.4 22.1 ±  10.2 27.0 'I: 12,6 22.4 ± 11.6
Mean serum cholesterol, 1977 (mmol/L) 5.5 ± 0.73 5.5 ± 0.75 7.3 ± 0,78 7.3 0.66
Cholesterol. 1995 (mmol/L) 6.1 ± 0.92 6.2 :!: 1,10 6.9 ± 1.2 7.2 ± Í .54
Percenlage with cholesterol >  6.5 mmol/L in 1995 (%) 36 41 58 69
'.f  .SUM.
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TABLE 5
Relation between fat intake and stage of change For men and women
Men (« 59) Women (ti 53 208}
1 3 4 5 I 3 5
{ti -  11) (n = 34) (// — 23) (n "  23)1 (/j =  102) (h *  32) (// — 19) (fi «  30) (w == 43) (n = 84)
Energy (kJ) 12 332 11 279 10 542 1 1 891 9988' 8505 9425 9212 8769 83412
Fat (% of energy)
Total 43.2 38.2 39.8 41.2 3 6, O'* 38.9 39.4 39.8 40.0 35.8’'
Saturated 15.6 14.0 14.6 14.8 12.8 ' 14.4 14.8 14.5 15,1 12.8V
Monou »saturated 15.1 13.3 14.0 14.5 1 L7 13.1 14.4 13.8 13,0 11.6
Polyunsaturated 9.5 8.6 8.7 9.3 9,3 9.1 8,0 9.2 8.9 9.3
1 *' Significantly different from other stages: J P < 0.001; 3 P <  0.01 ; ? P < 0.0001; ■' P <  0.0004.
in Holland, as elsewhere in Europe, recommend reduction of 
fat intake to 30-35% of energy. In the whole high-risk group, 
87 men of the 254 patients (34%) had a serum cholesterol 
concentration ^  6,5 mmol/L and a dietary intake of >  35% of 
energy as fat. In women* 68 of the 218 patients (31%) needed 
dietary advice. Only 25% of the total high-risk group had a 
dietary intake of <35% of energy as fat.
The relation between stage of change and fat intake is shown 
in Table 5. Energy intake was higher in men than in women. 
Fat intake differed among the stages of change: subjects in 
stage 1 of change had the highest fat intake and subjects in 
stage 5 the lowest. This relation was more clear for men. 
Energy and fat intakes of patients in stage 5 were different from 
intakes of patients in the other stages and this difference was 
significant in both men and women. The lack of correlation 
between the stage of change and high and low cholesterol 
concentrations in the intervention and control groups confirms 
that attitude to diet is not explained by the intervention in 1977.
DISCUSSION
This study investigated the effect of nutritional counseling 
on cardiovascular risk factors 17 y after the intervention. No 
differences were found in serum cholesterol or fat intake be­
tween the intervention and control groups. One year after the 
intervention period a significant decrease had been found in 
serum cholesterol and blood pressure in the intervention group. 
Our findings in the present study agree with a 5-y follow-up in 
this cohort, in which no differences were found in cardiovas­
cular risk factors between the intervention and control groups 
(15, 16).
The general practices in this study are involved in the 
Nijmegen Monitoring Project, in which continuous feedback is 
given to the practices on patients under treatment for hyper­
tension and diabetes. It is to be expected that the lower blood 
pressures found in 1995 are an effect of this monitoring and 
treatment of hypertension. But this effect has been directed at 
both intervention and control groups; 33% of patients were 
being treated for hypertension in 1995. Further analysis of 
blood pressure figures showed a greater decrease in blood 
pressure in patients under treatment for hypertension and a 
small increase for patients not under treatment for hypertension 
(data not shown).
For dietary advice there is no guideline in general practice. 
Despite intensive nutrition counseling in the intervention 
group, no difference in attitude between the two groups could
be shown. The mean serum cholesterol concentration in both 
groups was higher than the mean in the Netherlands for that age 
group ( i 7), A considerable number of patients (78% of the men 
and 70% of the women) who are at high risk for cardiovascular 
diseases had unfavorable fat intakes, although r-20%> of the 
patients answered that they had visited a dietitian in the past
17 y.
We know of no other study in family practice in which the 
stage-of-change measurement was included. Stage of change 
was an independent factor in predicting fat intake in patients 
who were at risk for cardiovascular disease, Subjects who were 
in the stage of maintenance of their dietary change had signif­
icantly lower fat intakes than did patients in other stages, 
especially patients in stage 1 (never thinking of changing diet 
behavior). In another study in general practice it was shown 
that tailored nutrition messages had a positive effect on pro­
moting dietary changes (18). Patients who were in the stage of 
maintaining dietary change did remember the message more 
often than those in other stages. Not remembering the conse­
quences of high blood cholesterol was accompanied by a more 
negative attitude toward changing the diet (19).
The only way to success seems to be behavioral change, as 
shown with the stage-of-change model, Nutritional advice 
should be more tailored. Before starting to change a patient's 
diet, a judgment about attitude must first: be gained. In contrast 
with the management of chronic diseases such as hypertension 
and diabetes for which the doctor has a greater influence by 
prescription of drugs, management of unfavorable diet habits 
requires another approach. ‘Further investigation is needed to 
look for strategies to use in general practice to change attitudes 
toward dietary habits of patients who are at high risk for 
cardiovascular disease. I I
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